Frequency Exchange Corp
0.17
USD
-0.02
(-8.26%)
CIK
1816133
ISIN
CA3580191078
CUSIP
358019107
Return %
Stock
S&P 500
1Y
-23.82
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
CAD
•
in mil. unless spec.Working Capital
CAD
•
in mil. unless spec.Growth Rates
CAD
•
in mil. unless spec.Quarterly Revenue
CAD
•
in mil. unless spec.Quarterly Earnings Per Share
CAD
•
in mil. unless spec.Quarterly Dividends Per Share
CAD
•
in mil. unless spec.Company Description
- CEO
- Stephen Davis
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Vancouver Canada
- IPO Date
- May 8, 2020
- Website
- frequencyexchangecorp.com
- Similar Companies
- Business
- Frequency Exchange Corp. is a Canadian digital health and wellness technology company engaged in the development, manufacturing, and commercialization of wearable bioenergetic frequency delivery systems. Incorporated in 2019 and headquartered in Vancouver, British Columbia, the company operates primarily through its wholly owned subsidiary, Frequency Health Technologies (Cda) Inc., formerly known as FREmedica Technologies Inc. Frequency Exchange Corp. specializes in non-invasive wellness technologies that deliver targeted, programmable frequencies designed to stimulate cellular communication, optimize energy, and promote holistic recovery. The company's primary product and service offerings comprise the NIKKI wearable frequency delivery system, a wrist-worn device utilizing gentle red light and pulsed frequency technology to administer targeted health frequencies; the NIKKI Connect mobile application, which allows users to browse, download, and synchronize customized frequency programs directly to the wearable device; proprietary frequency program suites, featuring specialized sets formulated for Lyme disease support, sleep optimization, pain alleviation, inflammation reduction, stress management, and physical recovery; legacy bioenergetic hardware, including the WAVE 1 frequency emitter; and digital software services delivering subscription-based access to expanding frequency libraries and firmware enhancements. Frequency Exchange Corp. markets its solutions to direct-to-consumer wellness buyers, chronic illness recovery patients, holistic health providers, and specialized wellness clinics across North America and select international jurisdictions including the United Arab Emirates. In recent operational developments, the company expanded its retail footprint in September 2026 by securing authorization to launch the NIKKI device on the Best Buy Marketplace in Canada in partnership with Ripple Distribution and TKG Partners. In August 2026, Frequency Exchange Corp. launched its NIKKI Lyme Wellness Program through a commercial referral relationship with Ergopathics, extending its reach to an established network of over 7,000 practitioner clinics throughout the United States. To fund its commercial acceleration, sales marketing, inventory procurement, and continued product development, the company closed the initial tranche of a private placement equity financing in September 2026 for gross proceeds of approximately 427,057 Canadian dollars. In the same period, the company reinforced its governance and scaling initiatives with the appointment of business strategist Dana Friesen to its Board of Directors and expanded global consumer awareness through marketing integrations and international media features including the documentary Superhuman 2: REBIRTH.